EP
ALT icon

Essential Partners’s Altimmune ALT Stock Holding History

Essential Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Buy
400
+373
+1,381% +$1.11K ﹤0.01% 2157
2026
Q1 		$83 Buy
+27
New +$115 ﹤0.01% 2741

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Essential Partners's ALT Position: Q2 2026 in Review

Essential Partners increased its Altimmune (ALT) stake by 1,381% in Q2 2026, buying an estimated $1.11K and bringing the position to 400 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Essential Partners first reported a position in ALT in Q1 2026 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Essential Partners held 400 shares of Altimmune worth $1.22K as of Q2 2026.
  • Essential Partners bought 373 Altimmune shares in Q2 2026, an estimated $1.11K.
  • Altimmune made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2157 holding.
  • Essential Partners first reported a position in Altimmune in Q1 2026 and has held it in 2 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.